New hope for PBC patients: drug targets debilitating itch
Symptom relief
Not yet recruiting
This study tests a new medicine called TH104 for people with primary biliary cholangitis (PBC) who suffer from moderate to severe itching. About 40 adults will receive either TH104 or a placebo to see if the drug is safe and helps reduce itch. The goal is to improve quality of li…
Phase: PHASE2 • Sponsor: Tharimmune Inc • Aim: Symptom relief
Last updated May 17, 2026 05:52 UTC